Exclusive Journals Coverage

Exclusive Journals Coverage articles provide quick insight and additional author perspectives on select studies recently published in Journal of Clinical Oncology and Journal of Oncology Practice.

Dec 07, 2015
In the low-dose morphine group, 88.2% experienced a 20% pain reduction; in the weak opioids group, the rate was 57.7%.
Nov 23, 2015
A study in JCO explores how the risk of basal cell carcinoma is affected  by external sources of estrogen and reproductive factors, such as age of first period, which affect the levels of estrogen in a woman’s body.
Nov 09, 2015
A study published in the JOP reviews the effect of task simulation to educate nurses on the use, care, and maintenance of central venous catheters (CVCs) on the rate of central-line associated bloodstream infections at the University of Vermont Medical Center.
Oct 25, 2015
By Shira Klapper, Senior Writer/Editor
Oct 19, 2015
This study found that serial imaging is not associated with increased overall survivial among survivors of DLBCL who had achieved complete response (CR).
Sep 30, 2015
A research team out of Cleveland Clinic carried out an intervention that significantly reduced the time between when patients with febrile neutropenia presented to the emergency department and when those patients received antibiotics.
Sep 08, 2015
Among the various breast cancer risk assessment tools currently available, the Breast Cancer Surveillance Consortium (BCSC) is the only one to include breast density as a risk factor (click here to see the online risk calculator). However, the BCSC has not included benign breast...
Aug 31, 2015
A new study in the Journal of Clinical Oncology (JCO) revealed several new findings about the four main symptoms of oxaliplatin-induced acute neuropathy and how these symptoms play out over time among oncology patients in a clinical setting. Neuropathy manifests as pain, numbness, tingling, or muscle weakness in the feet, hands,...
Aug 24, 2015
Lab studies have shown that gastric cancer cell lines with low levels of ataxia telangiectasia mutated (ATM)—which plays a key role in activating the repair response to DNA damage—are particularly sensitive to olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor. PARP inhibitors target tumors with deficiencies in the repair of double-strand...
Aug 10, 2015
A new study in the Journal of Oncology Practice (JOP), “Lifestyle Behaviors in Elderly Cancer Survivors: A Comparison with Middle-Age Cancer Survivors,” found that older patients—defined as 65 and older—differ significantly from younger patients in terms of how they perceive behavioral modifications in smoking and alcohol...

Pages